| ACINACI SHENZHEN JIELIANG TRADING CO. LTD. 2224664 28 Nov 2022 | on 16 Aug 2024 | Adapter cables for headphones; audio receivers; battery chargers for c... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Adapter cables for headphones; audio receivers; battery chargers for cell phones; cabinets for loudspeakers; computer keyboards; computer mouse; data synchronization cables; docking stations for digital music players; docking stations for laptops; docking stations for smartphones; ear pads for earphones; earbuds; earphone accessories, namely, earphone cases; earphones; extension cords; headphones; headsets for virtual reality games; microphones; USB chargers; USB hubs; wireless headphones | |
| BREFQI GLAXO GROUP LIMITED 2229961 28 Nov 2022 | on 5 Jul 2024 | Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, pulmonary, cardiorenal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the treatment of blood diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle cell disease, anaemia, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, ligament injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin infections namely acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of irritable bowel disorders and symptoms, digestive disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrhea and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids and Leiomyoma; pharmaceutical preparations and substances for use in urology, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, cirrhosis, cholestatic pruritus and primary biliary cholangitis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and psychoses; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines for human use; pharmaceutical preparations for the treatment of central nervous system and neurological diseases and disorders namely Parkinsons disease, Alzheimers disease, Huntingtons disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of nephrological related diseases and disorders. | |
| HALNIVI GLAXO GROUP LIMITED 2229962 28 Nov 2022 | on 26 Jul 2024 | Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, pulmonary, cardiorenal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the treatment of blood diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle cell disease, anaemia, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, ligament injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin infections namely acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of irritable bowel disorders and symptoms, digestive disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrhea and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids and Leiomyoma; pharmaceutical preparations and substances for use in urology, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, cirrhosis, cholestatic pruritus and primary biliary cholangitis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and psychoses; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines for human use; pharmaceutical preparations for the treatment of central nervous system and neurological diseases and disorders namely Parkinsons disease, Alzheimers disease, Huntingtons disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of nephrological related diseases and disorders. | |
| HALNUVI GLAXO GROUP LIMITED 2229969 28 Nov 2022 | on 26 Jul 2024 | Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, pulmonary, cardiorenal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the treatment of blood diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle cell disease, anaemia, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, ligament injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin infections namely acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of irritable bowel disorders and symptoms, digestive disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrhea and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids and Leiomyoma; pharmaceutical preparations and substances for use in urology, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, cirrhosis, cholestatic pruritus and primary biliary cholangitis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and psychoses; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines for human use; pharmaceutical preparations for the treatment of central nervous system and neurological diseases and disorders namely Parkinsons disease, Alzheimers disease, Huntingtons disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of nephrological related diseases and disorders. | |
| WYNJAERI GLAXO GROUP LIMITED 2229966 28 Nov 2022 | on 26 Jul 2024 | Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, pulmonary, cardiorenal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the treatment of blood diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle cell disease, anaemia, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, ligament injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin infections namely acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of irritable bowel disorders and symptoms, digestive disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrhea and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids and Leiomyoma; pharmaceutical preparations and substances for use in urology, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, cirrhosis, cholestatic pruritus and primary biliary cholangitis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia and psychoses; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines for human use; pharmaceutical preparations for the treatment of central nervous system and neurological diseases and disorders namely Parkinsons disease, Alzheimers disease, Huntingtons disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of nephrological related diseases and disorders. | |
| PREEMI Canadian Premature Babies Foundation-Fondation pour Bebes Prematures Canadiens 2224612 28 Nov 2022 | on 20 Dec 2024 | Plush toys Class 028 Class 028 Toys and Sporting Goods Products Plush toys | |
| YOGAVNI Vooma Corporation 2224603 28 Nov 2022 | on 5 Mar 2025 | Aromatherapy oils; aromatic essential oils; aromatic oils for the bath... Class 003 Class 003 Cosmetics and Cleaning Products Aromatherapy oils; aromatic essential oils; aromatic oils for the bath; bath oils; bath oils and bath salts; bath oils and bath salts, not for medical purposes; bath oils, not for medical purposes; body oils; essential oils for aromatherapy; essential oils for aromatherapy use; essential oils for personal use; essential oils for personal use and essential oils for aromatherapy; essential oils for personal use, aromatic essential oils, essential oils for cosmetic purposes, essential oils for aromatherapy; essential oils for soothing the nerves; essential oils for the manufacture of perfumes; essential oils for use as a room fragrance; essential oils for use in aromatherapy; essential oils of cedarwood; essential oils of citron; essential oils of lemon; essential oils of sandalwood; ethereal oils for the manufacture of perfumes; eucalyptus essential oil for use in aromatherapy; eye pillows; face oils; face oils for cosmetic purposes; facial masks to remove excess oil from the face; fragrance emitting wicks for room fragrance, room fragrance refills for electric and non-electric room fragrance dispensers, scented oils used to produce aromas when heated, home fragrance oils; fragrance refills for electronic essential oil diffusers; fragrance refills for plug-in essential oil diffusers; fragrance sachets for eye pillows; incense; incense and incense cones; incense cones; incense spray; incense sticks; lavander essential oil for use in aromatherapy; lavender massage oil; lavender oil; lavender oil for cosmetic use; lemongrass essential oil for use in aromatherapy; massage oils; massage oils and lotions; perfumery, incenses and fragrances; potpourri sachets for incorporating in aromatherapy pillows; rosemary essential oil for use in aromatheraphy Class 020 Class 020 Furniture Products Bed mattresses, pillows; bed pillows; bed rests; beds, bed frames, pillows, bolsters, feather beds, futon mattresses, mattress cushions, mattress foundations, mattress toppers, box springs; decorative pillows; fitted mattress pads; fitted mattress toppers; head supporting pillows; head-supporting pillows; mattress pads; mattress toppers; mattresses and mattress toppers; mattresses and pillows; mattresses, mattress foundations and pillows; mattresses, mattress foundations, pillows; mattresses, mattress toppers, and bed pillows; mattresses, pillows, box springs and mattress toppers; mattresses, pillows, mattress foundations, adjustable bed bases; mattresses, pillows, mattress toppers and mattress foundations; neck pillows; pillows; pillows, mattress toppers; throw pillows; travel pillows Class 021 Houseware and Glass Products Candle holders; incense burners; incense holder
Bath towels; bathroom towels of textile; beach towels; bed and bath linens; bed and table linen; bed blankets; bed blankets made of cotton; bed blankets, mattress covers, comforters, pillow covers; bed coverings; bed covers; bed linen; bed linens; bed pads; bed quilts; bed sheet sets; bed sheets; bed sheets for children; bed skirts; bed spreads; bed throws; blanket throws, blankets, bedding, sheets for bedding; blankets; children's pillow cases; children's towels; cloth towels; comforters, sheets, pillow cases, pillow shams, bed skirts, quilts, blankets, throws, towels, bath towels, shower curtains; cotton face towels; cotton hand towels; cotton towels; covers for duvets; covers for mattresses; curtains; curtains made of textile fabrics; curtains of textile; dish towels for drying; drapery curtains; duvet covers; duvets; duvets and comforters; face towels made of cotton; face towels made of textile materials; face towels of textile; face towels of textiles; fitted mattress covers; flat bed sheets; hand towels; hand towels made of cotton; hand towels made of textile materials; hand towels of cotton; hand towels of textile; kitchen towels of cloth; kitchen towels of textile; large bath towels; linen curtains; mattress covers; mattress protectors; mattress protectors in the nature of mattress covers; microfiber towels; microfibre towels; pillow cases; pillow covers; pillow protectors; pillow shams; pleated curtains; quilted mattress covers; sheets; shower curtains; shower curtains of textile or plastic; shower room curtains; silk pillow cases; table and bed linen; window curtains | |
| Kinmemai TOYO RICE CORPORATION 2236979 28 Nov 2022 | on 19 Mar 2025 | Processed grains, namely, flour, oats, flax seeds, quinoa, rice, mille... Class 030 Class 030 Staple Food Products Processed grains, namely, flour, oats, flax seeds, quinoa, rice, millet, bulgar, barley, wheat, rye and corn; sushi; boxed lunches consisting of rice, with added meat, fish or vegetables; rice; brown rice; processed rice; processed brown rice; onigiri [rice balls]; boxed lunches consisting of brown rice, with added meat, fish or vegetables; seasoned brown rice; brown rice takikomi-gohan (Japanese dish consisting primarily of boiled brown rice seasoned with soy sauce and mixed with meat or seafood and vegetables); onigiri [brown rice balls]; brown rice sushi; cooked rice; packaged cooked rice intended to be heated in a microwave oven or boiling water; packaged cooked brown rice intended to be heated in a microwave oven or boiling water; rice-based prepared meals; aseptically-packaged cooked rice; cooked brown rice; retort-pouched cooked brown rice; aseptically-packaged cooked brown rice; rice flour; brown rice flour; bread and buns; pancake mixes; instant rice; steamed rice. | |
| CONFETTI CONFETTI FINE FOODS PRIVATE LIMITED 2230995 25 Nov 2022 | on 25 Apr 2024 | Vegetable chips. Class 029 Class 029 Meats and Processed Food Products Vegetable chips. | |
| INSIMTRI OTSUKA PHARMACEUTICAL CO. LTD. 2234391 25 Nov 2022 | on 23 Aug 2024 | Pharmaceutical preparations for the treatment of central nervous syste... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; neurological and psychological pharmaceutical preparations for the treatment of eating disorders and addictions; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions. | |